Biomarker detection using TruSight® Oncology 500
/
Melanoma is the third most common cancer in Australia, with an average of one person diagnosed every 30 minutes.
Read More
Polygenic Risk Score for glaucoma
/
AGRF is partnering with SeonixBio to support the development and clinical implementation of a genetic risk prediction test for glaucoma. Assessing genetic risk of developing glaucoma will enable individuals to monitor for symptoms and make treatment decisions.
Read MoreUnravelling the Black Tiger Prawn Transcriptome
/
AGRF is a proud partner of The Australian Research Council Industrial Transformation Research Hub (ARC ITRH) for Advanced Prawn Breeding, which is applying cutting-edge genetic and genomic selection methodologies in the most advanced and industry-transformative improvement program for any prawn/shrimp species globally.
Read More
